NSC |
Compound |
Enrichment |
Correlation |
NSC 4290 |
Null |
0.0220039422291541 |
0.046032793 |
NSC 47786 |
9H-Purin-2-amine, 6-[[(2,4-dichlorophenyl)methyl]thio]-9-(2-methylpropyl)- |
0.0220039422291541 |
0.01429071 |
NSC 624114 |
Null |
0.0220039422291541 |
-0.049819609 |
NSC 665925 |
Null |
0.0220039422291541 |
0.1258984 |
NSC 633781 |
1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate |
0.0228506033927954 |
-0.10771063 |
NSC 101003 |
Null |
0.0228506033927957 |
0.33224544 |
NSC 731131 |
2-[4-(fluoro)benzylamino]-3-phenyl-5,7-diaminoquinoxaline |
0.0260391472224207 |
-0.20556528 |
NSC 750493 |
2-(2-hydroxyphenyl)-3-[5-(1H-imidazol-1-ylmethyl)-1,3,4-oxadiazol-2-yl]-1,3-thiazolidin-4-one |
0.0260391472224207 |
0.10104699 |
NSC 105827 |
SANGIVAMYCIN,-THIO |
0.0267520285931239 |
0.13858212 |
NSC 132791 |
Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo |
0.0267520285931239 |
0.037818958 |